Recombinant CSF1R (Cabiralizumab Biosimilar) antibody
The Human Monoclonal anti-CSF1R (Cabiralizumab Biosimilar) antibody is suitable to detect CSF1R (Cabiralizumab Biosimilar) in samples from Human. It has been validated for ELISA, FACS, BLI, Func and SPR.
Catalog No. ABIN7675734
$346.15
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant CSF1R (Cabiralizumab Biosimilar) antibody (ABIN7675734)
Target
CSF1R (Cabiralizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This CSF1R (Cabiralizumab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-CSF1R / M-CSFR / CD115 Reference Antibody (cabiralizumab)
-
Characteristics
- Anti-CSF1R / M-CSFR / CD115 Reference Antibody (cabiralizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4 S228P
-
-
anti-CSF1R (Cabiralizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- CSF1R (Cabiralizumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P07333
Target
-
You are here:
